CB vs PACB · P/E 14, rev $59.40B vs rev $38.4M
Chubb Ltd (CB) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. PACB currently screens at market cap $387.1M.
Not investment advice. Open the CB and PACB stock pages for the full models.
Not investment advice.